For research use only. Not for therapeutic Use.
Cinoctramide is an intermediate of pharmaceutical synthesis. Cinoctramide can be used for the research of autoimmune diseases[1].
| Catalog Number | I002973 |
| CAS Number | 28598-08-5 |
| Synonyms | (E)-1-(azocan-1-yl)-3-(3,4,5-trimethoxyphenyl)prop-2-en-1-one |
| Molecular Formula | C19H27NO4 |
| Purity | ≥95% |
| InChI | InChI=1S/C19H27NO4/c1-22-16-13-15(14-17(23-2)19(16)24-3)9-10-18(21)20-11-7-5-4-6-8-12-20/h9-10,13-14H,4-8,11-12H2,1-3H3/b10-9+ |
| InChIKey | MDGVCMGGLSOVIQ-MDZDMXLPSA-N |
| SMILES | COC1=CC(=CC(=C1OC)OC)C=CC(=O)N2CCCCCCC2 |
| Reference | [1]. Joshua David Mezrich, et al. Method of Treating Transplant Rejection and Autoimmune Diseases. Patent US20180042899A1. |
